methyl (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutanoate | 134848-77-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutanoate
• CAS: 134848-77-4
• 化学式: C₁₁H₂₁NO₃
• 分子量: 215.293
• InChiKey: GZFOVXVUPOFQGM-VHSXEESVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutanoate 在 三甲基铝 、 三乙胺 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 3.0h， 生成 (4S,5R)-4-(cyclohexylmethyl)-5-(1-oxo-4-pentenyl)-2-oxazolidinone
  参考文献：
  名称：

  Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors

  摘要：

  Using a computer model of the active site of human renin developed at Merck, we designed a series of novel P2-P1'-linked, macrocyclic renin inhibitors 3-10. These unique inhibitors incorporate a transition-state isostere within a 13- or 14-membered ring. The three most active compounds in this family were 13-membered-ring glutamine-derived inhibitor 3, 14-membered-ring diaminopropionic acid derived inhibitor 6, and 13-membered-ring diol 9 (IC50 0.61, 0.59, 0.65-mu-M, respectively). Modification of inhibitor 3 at P4 led to 56 nM macrocyclic renin inhibitor 39. This study shows the viability of renin inhibitor designs which incorporate a scissile-bond replacement within a macrocycle.

  DOI：

  10.1021/jm00113a005
• 作为产物：
  描述：

  甲醇 、 (2R,3S)-nor-C-statine hydrochloride 在 氯化亚砜 作用下， 生成 methyl (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutanoate
  参考文献：
  名称：

  A Practical Synthesis ofthreo-3-Amino-2-hydroxycarboxylic Acids

  摘要：

  已经通过在相转移条件下，以α-碳氧基氨基醛为起始物，进行高度非对映选择性的氰醇酸乙酯的形成，迅速合成了（2R,3S）-3-氨基-4-环己基-2-羟基丁酸（2）和（2S,3R）-3-氨基-2-羟基-4-苯基丁酸（4），这两者分别是肾素抑制剂（1）和贝斯坦（3）的关键成分。

  DOI：

  10.1246/bcsj.65.360

文献信息

• Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors
  作者：Ann E. Weber、Thomas A. Halgren、John J. Doyle、Robert J. Lynch、Peter K. S. Siegl、William H. Parsons、William J. Greenlee、Arthur A. Patchett

  DOI：10.1021/jm00113a005

  日期：1991.9

  Using a computer model of the active site of human renin developed at Merck, we designed a series of novel P2-P1'-linked, macrocyclic renin inhibitors 3-10. These unique inhibitors incorporate a transition-state isostere within a 13- or 14-membered ring. The three most active compounds in this family were 13-membered-ring glutamine-derived inhibitor 3, 14-membered-ring diaminopropionic acid derived inhibitor 6, and 13-membered-ring diol 9 (IC50 0.61, 0.59, 0.65-mu-M, respectively). Modification of inhibitor 3 at P4 led to 56 nM macrocyclic renin inhibitor 39. This study shows the viability of renin inhibitor designs which incorporate a scissile-bond replacement within a macrocycle.
• A Practical Synthesis of<i>threo</i>-3-Amino-2-hydroxycarboxylic Acids
  作者：Fuyuhiko Matsuda、Teruyo Matsumoto、Masako Ohsaki、Yoshio Ito、Shiro Terashima

  DOI：10.1246/bcsj.65.360

  日期：1992.2

  An expeditious synthesis of (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutyric acid (2) and (2S,3R)-3-amino-2-hydroxy-4-phenylbutyric acid (4), the key components of the renin inhibitor (1) and bestatin (3), respectively, have been accomplished by featuring highly diastereoselective formation of cyanohydrin acetates from α-alkoxycarbonylamino aldehydes under phase-transfer conditions.

  已经通过在相转移条件下，以α-碳氧基氨基醛为起始物，进行高度非对映选择性的氰醇酸乙酯的形成，迅速合成了（2R,3S）-3-氨基-4-环己基-2-羟基丁酸（2）和（2S,3R）-3-氨基-2-羟基-4-苯基丁酸（4），这两者分别是肾素抑制剂（1）和贝斯坦（3）的关键成分。